Uncategorized

22
Apr

FDA Says its Recent QSR Amendment will Streamline the Path to Market for Medical Device Providers

GET EXPERT ADVICE AT MEDTECH FORUM 2022 After four years in the works, the U.S. Food and Drug Administration (FDA) has finally published their much-anticipated proposed rule (PR) to amend the Quality System Regulation (QSR) (21 CFR Part 820) on 2/23/2022. This proposed rule not only impacts U.S. manufacturers but all manufacturers with product in […]

Read More
09
Feb

Frances Zipp to Moderate WiHP Healthcare Leadership Luncheon at AAM Annual Meeting

Join Frances Zipp, President and CEO of Lachman Consultant Services, Inc., at the AAM Annual Conference, Access! 2022, where she will moderate the WiHP Healthcare Leadership luncheon. The panel discussion will be held on February 15, 2022, at 12:30 pm. Frances will be joined by AMCP CEO Susan Cantrell, AHIP’s EVP of Government Affairs and […]

Read More
09
Feb

Frances Zipp to Moderate WiHP Healthcare Leadership Luncheon at AAM Annual Meeting

Join Frances Zipp, President and CEO of Lachman Consultant Services, Inc., at the AAM Annual Conference, Access! 2022, where she will moderate the WiHP Healthcare Leadership luncheon. The panel discussion will be held on February 15, 2022, at 12:30 pm. Frances will be joined by AMCP CEO Susan Cantrell, AHIP’s EVP of Government Affairs and […]

Read More
13
Dec

Confused About the Global Requirements for Nitrosamines?

Confused About the Global Requirements for Nitrosamines? We will Help You Navigate This Unchartered Territory! Nitrosamines are a well characterized family of carcinogens that has been identified in thousands of consumer products recently, including small molecule pharmaceuticals and other finished goods. They are produced by the chemical reactions of a nitrosating agent with structural elements […]

Read More
07
Dec

Just in Case You Couldn’t Attend – The Lachman Learning Experience Data Integrity Webinar

Data integrity is an ever-increasing concern in the life sciences as evidenced by the recent activities of the FDA placing its watchful eye on the evolving medical device industry. To help manufacturers better understand, establish, and maintain data integrity under growing regulatory scrutiny, Lachman Consultant Services, Inc. (Lachman Consultants) hosted a free webinar on Wednesday, […]

Read More
16
Nov

AAM All Access Podcast Special Featuring Bob Pollock Now Available!

Last week, Lachman hosted a virtual booth at the GRx+Biosims 2021 interactive event, where we engaged in a series of dynamic discussions around issues, trends, and challenges vital to the generic and biosimilar medicines industry. The three-day event also featured a podcast special with AAM CEO Dan Leonard and Lachman Senior Advisor Bob Pollock. The […]

Read More
1 2 3 6